BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1676 related articles for article (PubMed ID: 15626447)

  • 21. Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles.
    Turcheniuk K; Tarasevych AV; Kukhar VP; Boukherroub R; Szunerits S
    Nanoscale; 2013 Nov; 5(22):10729-52. PubMed ID: 24091568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
    Ma HL; Qi XR; Maitani Y; Nagai T
    Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethylene glycol-protected magnetic nanoparticles for a multiplexed immunoassay in human plasma.
    Lin PC; Chou PH; Chen SH; Liao HK; Wang KY; Chen YJ; Lin CC
    Small; 2006 Apr; 2(4):485-9. PubMed ID: 17193071
    [No Abstract]   [Full Text] [Related]  

  • 24. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
    Steitz B; Salaklang J; Finka A; O'Neil C; Hofmann H; Petri-Fink A
    Bioconjug Chem; 2007; 18(5):1684-90. PubMed ID: 17718533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences.
    Jun YW; Seo JW; Cheon J
    Acc Chem Res; 2008 Feb; 41(2):179-89. PubMed ID: 18281944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
    Ma HL; Qi XR; Ding WX; Maitani Y; Nagai T
    J Biomed Mater Res A; 2008 Mar; 84(3):598-606. PubMed ID: 17618488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
    Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
    Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomedical microdevices synthesis of iron oxide nanoparticles using a microfluidic system.
    Lee WB; Weng CH; Cheng FY; Yeh CS; Lei HY; Lee GB
    Biomed Microdevices; 2009 Feb; 11(1):161-71. PubMed ID: 18756355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising iron oxide-based magnetic nanoparticles in biomedical engineering.
    Tran PH; Tran TT; Vo TV; Lee BJ
    Arch Pharm Res; 2012 Dec; 35(12):2045-61. PubMed ID: 23263800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
    Smirnov P
    Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
    Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
    Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells.
    Villanueva A; CaƱete M; Roca AG; Calero M; Veintemillas-Verdaguer S; Serna CJ; Morales Mdel P; Miranda R
    Nanotechnology; 2009 Mar; 20(11):115103. PubMed ID: 19420433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling transport and chemical functionality of magnetic nanoparticles.
    Latham AH; Williams ME
    Acc Chem Res; 2008 Mar; 41(3):411-20. PubMed ID: 18251514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterization of SiO2/(PMMA/Fe3O4) magnetic nanocomposites.
    Wang Z; Guo Y; Li S; Sun Y; He N
    J Nanosci Nanotechnol; 2008 Apr; 8(4):1797-802. PubMed ID: 18572580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of iron oxide nanoparticles and quantum dots into silica microspheres.
    Insin N; Tracy JB; Lee H; Zimmer JP; Westervelt RM; Bawendi MG
    ACS Nano; 2008 Feb; 2(2):197-202. PubMed ID: 19206619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Size control of magnetic carbon nanoparticles for drug delivery.
    Oh WK; Yoon H; Jang J
    Biomaterials; 2010 Feb; 31(6):1342-8. PubMed ID: 19878989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
    Martin AR; Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
    Gupta AK; Gupta M
    Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
    Kettering M; Zorn H; Bremer-Streck S; Oehring H; Zeisberger M; Bergemann C; Hergt R; Halbhuber KJ; Kaiser WA; Hilger I
    Phys Med Biol; 2009 Sep; 54(17):5109-21. PubMed ID: 19661569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonpolymeric Coatings of Iron Oxide Colloids for Biological Use as Magnetic Resonance Imaging Contrast Agents.
    Portet D; Denizot B; Rump E; Lejeune JJ; Jallet P
    J Colloid Interface Sci; 2001 Jun; 238(1):37-42. PubMed ID: 11350133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.